These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11829449)
1. The current management of diabetic dyslipidaemia. Betteridge DJ Acta Diabetol; 2001; 38 Suppl 1():S15-9. PubMed ID: 11829449 [TBL] [Abstract][Full Text] [Related]
2. What does the future hold for diabetic dyslipidaemia? Crespin SR Acta Diabetol; 2001; 38 Suppl 1():S21-6. PubMed ID: 11829450 [TBL] [Abstract][Full Text] [Related]
3. Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins. Papadakis JA; Milionis HJ; Press M; Mikhailidis DP J Diabetes Complications; 2001; 15(4):211-26. PubMed ID: 11457674 [TBL] [Abstract][Full Text] [Related]
4. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia. Goa KL; Barradell LB; Plosker GL Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820 [TBL] [Abstract][Full Text] [Related]
5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
6. Diabetic dyslipidaemia: insights for optimizing patient management. Vergès B Curr Med Res Opin; 2005; 21 Suppl 1():S29-40. PubMed ID: 15811197 [TBL] [Abstract][Full Text] [Related]
7. [Diabetic dyslipidaemia and the atherosclerosis]. Márk L; Dani G Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274 [TBL] [Abstract][Full Text] [Related]
8. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes. Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404 [TBL] [Abstract][Full Text] [Related]
9. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study. García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D; Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149 [TBL] [Abstract][Full Text] [Related]
11. Current, new and future treatments in dyslipidaemia and atherosclerosis. Chong PH; Bachenheimer BS Drugs; 2000 Jul; 60(1):55-93. PubMed ID: 10929930 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus: an update. Hovens MM; Tamsma JT; Beishuizen ED; Huisman MV Drugs; 2005; 65(4):433-45. PubMed ID: 15733008 [TBL] [Abstract][Full Text] [Related]
13. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia. Keating GM; Ormrod D Drugs; 2002; 62(13):1909-44. PubMed ID: 12215067 [TBL] [Abstract][Full Text] [Related]